2-({[(4-Chlorophenyl)amino]carbonyl}amino)-1,3-thiazole-4-carboxylic acid, 95.0%, 500mg

2-Fluoroacrylic acid, 98%, 10g

Trans-3-chloroacrylic acid, 98+%, 1g

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 1g

TERT-BUTYL ((4-AMINOBICYCLO[2.2.2]OCTAN-1-YL)METHYL)CARBAMATE, 95%, 1g

Methyl (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, 95%, 250mg

Colonne capillaire GC ROTI®Cap-1701, 50 m, 0,32 mm, 0,50 µm, 1 pièce(s)

5,7-Dimethyl-4-nitro-1H-indole, 95+%, 5g

1-Acetyl-2,3-dihydro-1H-indole-6-sulfonic acid amide, 95.0%, 500mg

3-(5-Mercapto-1,3,4-oxadiazol-2-yl)benzonitrile, 95.0%, 100mg

5-Octyl-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione, 95.0%, 250mg

2-Aminoethyl hydrogen sulfate, 97.0%, 1kg

1-(6-Nitro-1,3-benzodioxol-5-yl)ethanol, 97.0%, 5g